Bristol Myers must face $6.7 billion lawsuit over delayed cancer drug, US judge rules
Bristol-Myers Squibb(US:BMY) Reuters·2025-12-01 21:48A U.S. judge on Monday rejected Bristol Myers Squibb's bid to dismiss a $6.7 billion lawsuit claiming it cheated shareholders of the former Celgene by delaying federal approval for three drugs, includ... ...